Jennifer Manning ’95 KOMO’s mission is to enable accelerated development and manufacturing of life-saving therapeutics by translating the utility of high-efficiency integrases to high-efficiency therapeutic development and manufacturing processes.
Jennifer Manning ’95 is founding CEO of KOMO BIOSCIENCES
September 30, 2024